The size of the cohort precluded multivariate analyses, and there was the additional inconvenience that the follow-up period coincided with the advent of the COVID-19 crisis, which hampered proper data gathering and patient surveying
It's like watering plants: regular, constant attention does better than periodic lushness and nothing for a week
Only three drugs have ever received FDA approval for AUDdisulfiram, naltrexone, and acamprosateand their limited use for AUD is traced to factors including stigma and poor public awareness of their potential benefit
GHK-CU, BPC 157, TB 500, KPV RECOVERY BLEND Known for its ability to: BPC-157 for tendons & gut, TB-500 for gentle daily recovery, KPV for inflammation & immunity, GHKCu for glow & repair
April 8, 2025: MDL Against Ozempic and Other GLP-1s Top 1,600 in April As of April 1, 2025, there are 1,685 active lawsuits pending against Novo Nordisk and other pharmaceutical companies that sold GLP-1 drugs like Ozempic